stockrowKiniksa Pharmaceuticals International, plc (KNSA) vs Dr. Reddy's Laboratories Ltd (RDY)
- Kiniksa Pharmaceuticals International, plc KNSA 88.50 −7.93%
- Dr. Reddy's Laboratories Ltd RDY 14.53 −1.62%
Kiniksa Pharmaceuticals International, plc and Dr. Reddy's Laboratories Ltd are both Drug Manufacturers Specialty & Generic companies. Dr. Reddy's Laboratories Ltd is the larger, with a market value of $12.1B against $6.9B — 1.7× the size. Dr. Reddy's Laboratories Ltd trades at the lower P/E: 44.4× against 62.1×. Kiniksa Pharmaceuticals International, plc grew revenue faster over the last twelve months: 58.2% against −15.5%. Kiniksa Pharmaceuticals International, plc has the higher net margin (11.6% vs 8.06%) and the higher return on invested capital (57.7% vs 4.77%). Across the 21 metrics below, Kiniksa Pharmaceuticals International, plc leads on 14 and Dr. Reddy's Laboratories Ltd on 7.
Valuation
Profitability
| Metric | KNSA | RDY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 90.16% | 49.16% | 53.51% |
| Operating margin | 13.79% | 9.20% | 0.00% |
| Net margin | 11.58% | 8.06% | (2.45%) |
| Free cash flow margin | 20.85% | 2.88% | 0.00% |
| Return on equity | 17.59% | 6.60% | (0.80%) |
| Return on assets | 12.92% | 4.44% | (1.67%) |
| Return on invested capital | 57.65% | 4.77% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack